Extended surveillance of gonorrhoea in Scotland 2003

International Journal of STD and AIDS

Volumn 17, Issue 10, 2006, Pages 687-692

  Young, Hugh ^a   McElhinney, J ^a   Palmer, H M ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Antibiotic resistance; Epidemiology; Gonorrhoea; Surveillance; Treatment

Indexed keywords

AZITHROMYCIN; CEPHALOSPORIN; CIPROFLOXACIN; PENICILLIN G; SPECTINOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; DEMOGRAPHY; ETHNIC GROUP; FEMALE; GONORRHEA; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIODIC MEDICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE FACTORS; AMBULATORY CARE FACILITIES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CEPHALOSPORINS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; FEMALE; GONORRHEA; HOSPITALS; HUMANS; MALE; MIDDLE AGED; NEISSERIA GONORRHOEAE; POPULATION SURVEILLANCE; PRIMARY HEALTH CARE; QUESTIONNAIRES; SCOTLAND; SEXUAL BEHAVIOR;

EID: 33750244573     PISSN: 09564624     EISSN: 09564624     Source Type: Journal    
DOI: 10.1258/095646206780070965     Document Type: Article

References (13)

1. PHLS, DHSS&PS and the Scottish ISD(D)5 Collaborative group. Trends in Sexually Transmitted Infections in the United Kingdom, 1990-1999. London: Public Health Laboratory Service, 2000
2. GRASP Steering Group. The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) Year 2003 Report. London: Health Protection Agency, 2004
3. Young H, Palmer H, Winter A. Ciprofloxacin resistant gonorrhoea: the situation in Scotland and implications for therapy. Scottish Centre for Infection and Environmental Health 2003;37:178-80
4. Young H, Palmer HM. Gonococcal antibiotic resistance in Scotland: trends 2000-2003. Scottish Centre for Infection and Environmental Health 2003;38:206-8
5. Ross JDC, Young H. Infectivity and clinical features of gonorrhoea: a serovar analysis. In: Conde-Glez CJ, Morse S, Rice P, Sparling F, Calderon E, eds. Pathobiology and Immunobiology of Neisseriaceae. 1st edn. Mexico: Instituto Nacional de Salud Publica, 1994;111-15
6. Young H, Moyes A, Ross JDC. Pharyngeal gonorrhoea: an increase in clinical and microbiological significance? In Conde-Glez CJ, Morse S, Rice P, Sparling F, Calderon E, eds. Pathobiology and Immunobiology of Neisseriaceae. 1st edn, Mexico: Instituto Nacional de Salud Publica, 1994;140-1
7. Manavi K, Young H, McMillan A. The outcome of oropharyngeal gonorrhoea treated with different regimens. Int J STD AIDS 2005;16:68-70
8. Palmer HM, Young H, Martin IMC, Ison CA, Spratt BG. The epidemiology of ciprofloxacin resistant isolates of Neisseria gonorrhoeae in Scotland 2002: a comparison of phenotypic and genotypic analysis. Sex Transm Infect 2005;81:403-7
9. Corkill JE, Kelly C, Neal T, Alawattegama AB, Hart CA. The rise and fall of ciprofloxacin-resistant Neisseria gonorrhoeae in Liverpool. Int J STD AIDS 2005;16:83
10. Waters LJ, Boag FC, Betournay R. Efficacy of azithromycin 1 g single dose in the management of gonorrhoea. Int J STD AIDS 2005;16:84
11. Young H, Moyes A, McMillan A. Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin. Int J STD AIDS 1997;8:299-302
12. Tapsall JW, Schultz TR, Limnios TA, Donovan B, Lum G, Mulhall BP. Failure of azithromycin therapy in gonorrhoea and discorrelation with laboratory parameters. Sex Transm Dis 1998;25:505-8
13. Bignell C. National guideline on the diagnosis and treatment of gonorrhoea in adults. 2005. Available on [www.bashh.org] (last accessed 19/09/05)